Other OTC - Delayed Quote • USD
Ayala Pharmaceuticals, Inc. (ADXS)
At close: 1:55 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-29,485.0000
-29,485.0000
-34,510.0000
-38,356.0000
-27,541.0000
--
Investing Cash Flow
5,946.0000
5,946.0000
-2.0000
-5.0000
181.0000
--
Financing Cash Flow
26,001.0000
26,001.0000
-103.0000
33,330.0000
52,922.0000
--
End Cash Position
5,212.0000
5,212.0000
2,724.0000
37,339.0000
42,370.0000
--
Income Tax Paid Supplemental Data
371.0000
371.0000
244.0000
209.0000
300.0000
--
Capital Expenditure
--
--
--
-5.0000
-45.0000
-1,330.0000
Issuance of Capital Stock
20,001.0000
20,001.0000
512.0000
33,229.0000
52,641.0000
--
Issuance of Debt
6,000.0000
6,000.0000
--
--
--
--
Repurchase of Capital Stock
--
--
-615.0000
--
--
--
Free Cash Flow
-29,485.0000
-29,485.0000
-34,510.0000
-38,361.0000
-27,586.0000
--
12/31/2019 - 5/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACST Acasti Pharma Inc.
2.6500
-1.49%
ARDS Aridis Pharmaceuticals, Inc.
0.0535
-12.01%
AIM AIM ImmunoTech Inc.
0.3969
-3.31%
QLGN Qualigen Therapeutics, Inc.
0.2875
+1.73%
PHGE BiomX Inc.
0.3448
-3.42%
TRAW Traws Pharma, Inc.
0.6325
-1.20%
IMNN Imunon, Inc.
1.4500
+1.40%
AFMD Affimed N.V.
4.7100
-1.88%
NBSE NeuBase Therapeutics, Inc.
0.3780
-1.56%
SLRX Salarius Pharmaceuticals, Inc.
0.4739
-0.69%